New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
10:27 EDTVSI, GNCGNC rises after upgrade, Vitamin Shoppe seen as potential partner
Shares of health and wellness product retailer GNC Holdings (GNC) are rising in early trading after analysts at Credit Suisse upgraded the stock. Additionally, the research firm said it remains "intrigued" about the potential for a merger between the company and its peer Vitamin Shoppe (VSI). WHAT'S NEW: In a note to investors this morning, Credit Suisse analysts Gary Balter and Andrew Kinder increased their rating on GNC shares to Outperform from Neutral, citing confidence in the company's CEO, Michael Archbold, and the stock's recent underperformance following earnings misses in its last three consecutive quarters. The analysts contend that GNC has a loyal customer base and that some changes to its cost base, store count and franchise terms could lead it to better results. Credit Suisse maintained its $43 price target on shares of GNC. WHAT'S NOTABLE: The analysts also stated that they "remain intrigued" by the potential for a merger between GNC and its rival Vitamin Shoppe. The two companies have a high degree of store overlap and Vitamin Shoppe would get the sports nutrition and manufacturing operations that it is "currently chasing through dilutive investments" by combining with GNC, the analysts wrote. The research note also pointed out that Archbold, who was appointed GNC's CEO just last week, previously served as the Chief Operating Officer and as the Chief Financial Officer of Vitamin Shoppe and that he has a "rich history with private equity funds." PRICE ACTION: Shares of GNC Holdings rose $1.31, or 4.01%, to $33.98 in mid-morning trading, while Vitamin Shoppe gained $1.06, or 2.82%, to $38.61.
News For GNC;VSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
07:29 EDTVSIVitamin Shoppe thesis unchanged despite activist investor stake, says Baird
Subscribe for More Information
April 22, 2015
16:44 EDTVSIOn The Fly: Top stock stories for Wednesday
Stocks on Wall Street began the session in positive territory, but turned negative shortly after the open. The downside move failed to gain momentum and the averages remained near the flat line for most of the morning. The market moved to session highs by mid-afternoon and drifted higher into the close, as investors prepared for another round of earnings reports. ECONOMIC EVENTS: In the U.S., existing home sales rose 6.1% to a 5.19M rate in March, which was better than the expected 3.1% increase to a rate of 5.03M. Crude oil inventories built up by 5.32M barrels last week, which was more than the consensus forecast for a 3.2M barrel build. In Asia, Japan's Nikkei 225 average closed above 20,000 for the first time since April 2000. In Europe, Germany raised its economic growth forecast for 2015 to 1.8%, which was up from the 1.5% growth it said it expected in January. COMPANY NEWS: Shares of Visa (V) rose $2.66, or 4.07%, to $68.01 and MasterCard (MA) advanced $3.43, or 3.91%, to $91.20 after China's State Council announced overnight that the country will regulate the market access for bankcard transaction clearing institutions, which analysts think might allow both companies to compete for the processing of domestic transactions in the country. Goldman Sachs said the overall rule is broader and simpler than expected, raising the possibility that Visa and MasterCard could operate more freely in China than the firm had previously expected... Shares of McDonald's (MCD) advanced $2.97, or 3.13%, to $97.84 after the company reported headline earnings that missed expectations but also said it is developing a turnaround plan to improve its performance and deliver "enduring profitable growth" that it plans to share in the first week of May. MAJOR MOVERS: Among the notable gainers was Organovo (ONVO), which surged 67c, or 14.99%, to $5.14 after disclosing the company entered into a multi-year research collaboration agreement with Merck (MRK) that gives the drugmaker access to Organovo’s commercial exVive3D Human Liver Tissue service. Also higher was Vitamin Shoppe (VSI), which gained $5.54, or 14.22%, to $44.50 after asset management firm Carlson Capital revealed that it had obtained a 5.34% stake in the company and said that it had held talks with the retailer of natural treatments, supplements and vitamins. Among the noteworthy losers was Natural Resource Partners (NRP), which dropped $1.38, or 19.94%, to $5.54 after the company slashed its quarterly distribution by 75% to 9c per unit. Also lower were shares of Chipotle Mexican Grill (CMG), which fell $51.29, or 7.41%, to $641.23 after the company reported lower than expected first quarter comparable sales growth of 10.4%. INDEXES: The Dow rose 88.68, or 0.49%, to 18,038.27, the Nasdaq gained 21.07, or 0.42%, to 5,035.17, and the S&P 500 advanced 10.67, or 0.51%, to 2,107.96.
13:44 EDTGNC, VSIVitamin Shoppe jumps after Carlson discloses 5% stake
The shares of Vitamin Shoppe (VSI) are climbing after asset management firm Carlson Capital revealed that it had obtained a 5.34% stake in the company and said that it had held talks with the retailer of natural treatments, supplements and vitamins. WHAT'S NEW: Carlson disclosed its stake in the company in an SEC filing and said that it had held talks with the company's board about a number of matters, including the company’s business, management and strategic alternatives and direction. Carlson said it would continue to hold talks with the company, and others, about these issues. WHAT'S NOTABLE: Vitamin Shoppe reported last October that it had spoken to investment banks about retaining a financial adviser, Reuters reported at the time. The retailer had come under pressure to consider selling the company, added the news service. In February, New York's attorney general accused a Vitamin Shoppe competitor, GNC (GNC) of selling products whose content did not match their labels. Vitamin Shoppe's CEO said that, despite the fact that it was not targeted by the attorney general, it saw a slight impact on its sales from the news, according to trade website NUTRA ingredients-usa.com. PRICE ACTION: In mid-afternoon trading, Vitamin Shoppe jumped 10.7% to $43.12, while GNC gained 2.8% to $47.25.
12:18 EDTGNC, VSICarlson Capital reports 5.34% stake in Vitamin Shoppe, says plans more talks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use